SCHEMBL4859239

SCHEMBL4859239

COc1ccc2cnoc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
HPGD P15428 3/20 0.49
KDM4E B2RXH2 2/20 0.49
HSD17B10 Q99714 2/20 0.49
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA3 P07451 1/20 0.49
AKR1B1 P15121 1/20 0.49
CA4 P22748 1/20 0.49
CA6 P23280 1/20 0.49
CA5A P35218 1/20 0.49
CA7 P43166 1/20 0.49
CA9 Q16790 1/20 0.49
CA14 Q9ULX7 1/20 0.49
CYP1A2 P05177 2/20 0.46
CYP11B1 P15538 2/20 0.46
CYP11B2 P19099 2/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2A6 P11509 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29489333 1.00 ALDH1A1 (0.49) ALDH1A1HPGDKDM4EHSD17B10CA12
SCHEMBL31392596 0.85 PDE3B (0.56) ALDH1A1HPGDKDM4EHSD17B10CA12
SCHEMBL9342415 0.85 PDE3B (0.56) ALDH1A1HPGDKDM4EHSD17B10CA12
SCHEMBL9211923 0.74 NCEH1 (0.57) ALDH1A1CA2RAB9AGAAMEN1
SCHEMBL12186 0.74 CYP1A2 (0.44) ALDH1A1HPGDKDM4EHSD17B10CYP1A2
SCHEMBL10580705 0.72 ALDH1A1 (0.50) ALDH1A1HPGDKDM4EHSD17B10CA12
SCHEMBL8799093 0.72 PDE3B (0.77) ALDH1A1HPGDKDM4EHSD17B10CA12
SCHEMBL16595870 0.71 NOS1 (0.45) ALDH1A1KDM4ECYP1A2CYP11B1CYP11B2
SCHEMBL29447161 0.71 CYP1A2 (0.79) KDM4ECA12CA1CA7CA9
SCHEMBL443070 0.71 CYP1A2 (0.79) KDM4ECA12CA1CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7393960-B2 Indoles having anti-diabetic activity MERCK & CO., INC. (US) 2008-07-01 US disclosed
EP-1546142-A4 INDOLES HAVING ANTI-DIABETIC ACTIVITY MERCK & CO INC (US) 2007-10-17 EP disclosed
US-20050272788-A1 peroxisome proliferator activated receptor agonist such as (2R)-2-(3-{[3-(4-chlorophenoxy)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl]methyl}phenoxy)butanoic acid, used for treatment and control of metabilic disorders MERCK SHARP & DOHME CORP. 2005-12-08 US disclosed
EP-1546142-A2 INDOLES HAVING ANTI-DIABETIC ACTIVITY Merck & Co., Inc. (US) 2005-06-29 EP disclosed
WO-2004019869-A2 INDOLES HAVING ANTI-DIABETIC ACTIVITY MERCK & CO., INC. (US) 2004-03-11 WO disclosed
US-4053318-A SENSITIZING MEROCYANINE DYE FUJI PHOTO FILM CO., LTD. (JA) 1977-10-11 US disclosed
US-4047964-A BENZISOXAZOLE FUJI PHOTO FILM CO., LTD. (JA) 1977-09-13 US disclosed
US-4021251-A Silver halide photographic emulsions FUJI PHOTO FILM CO., LTD. (JA) 1977-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272788-A1 peroxisome proliferator activated receptor agonist such as (2R)-2-(3-{[3-(4-chlorophenoxy)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl]methyl}phenoxy)butanoic acid, used for treatment and control of metabilic disorders PPARA, GPR119, PPARG ALDH1A1 1448/4885HPGD 1384/4885KDM4E 2281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.